M
Matthew D. Thompson Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Assistant Professor
faculty
16 h-index
77 pubs
874 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Matthew D. Thompson, Assistant Professor at the University of Arkansas for Medical Sciences, investigates trends in cancer treatment and patient survival outcomes. His work includes analyses of real-world data to understand prescription patterns for systemic anticancer therapies in advanced non-small cell lung cancer. Thompson has also published research on the role and regulation of helicases at the replication fork, structural features of Dda helicase, and the application of multi-omics data integration for understanding triple-negative breast cancer.
His research has extended to pharmacokinetic modeling for dose selection of immune-activating products in oncology and assessing the use of bone-targeting agents in patients with bone metastasis. Thompson collaborates with researchers at the University of Arkansas for Medical Sciences, including Maroof Zafar, Emory G. Malone, Lindsey Hazeslip, and Duah Alkam, with whom he has co-authored multiple publications. He has an h-index of 16, with 77 total publications and 868 total citations.
Metrics
- h-index: 16
- Publications: 77
- Citations: 874
Selected Publications
-
Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments (2025)
-
Rare SNP in the <i>HELB</i> gene interferes with RPA interaction and cellular function of HELB (2025)
-
Untargeted CUT&Tag and BG4 CUT&Tag are both enriched at G-quadruplexes and accessible chromatin (2024)
-
Rare SNP in the <i>HELB</i> gene interferes with RPA interaction and cellular function of HELB (2024)
-
Role and Regulation of Pif1 Family Helicases at the Replication Fork (2022)
-
Monitoring helicase-catalyzed unwinding of multiple duplexes simultaneously (2022)
-
A structural feature of Dda helicase which enhances displacement of streptavidin and <i>trp</i> repressor from <scp>DNA</scp> (2021)
-
Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer (2021)
Collaboration Network
Top Collaborators
Alicia K. Byrd
Winthrop Rockefeller Foundation
9 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- Role and Regulation of Pif1 Family Helicases at the Replication Fork
- A structural feature of Dda helicase which enhances displacement of streptavidin and <i>trp</i> repressor from <scp>DNA</scp>
- Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments
- Untargeted CUT&Tag and BG4 CUT&Tag are both enriched at G-quadruplexes and accessible chromatin
Showing 5 of 9 shared publications
Kristopher W. Krausz
5 shared publications
- Supplementary Data from Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study
- Supplementary Figure 7 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 5 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Frank J. Gonzalez
5 shared publications
- Supplementary Data from Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study
- Supplementary Figure 7 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 5 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Ashkan Emadi
5 shared publications
- Cancer Pharmacology
- Cancer Pharmacology
- Cancer Pharmacology
- Cancer Pharmacology
- Cancer Pharmacology
Sue Cheeseman
Bexley Hall (US)
4 shared publications
- Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative
- Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative
- Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital
- Algorithms to identify radiotherapy intent in unresected non-metastatic non-small-cell lung cancer: an I-O Optimise analysis
Maroof K. Zafar
University of Arkansas for Medical Sciences
4 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- A structural feature of Dda helicase which enhances displacement of streptavidin and <i>trp</i> repressor from <scp>DNA</scp>
- Rare SNP in the <i>HELB</i> gene interferes with RPA interaction and cellular function of HELB
- Rare SNP in the <i>HELB</i> gene interferes with RPA interaction and cellular function of HELB
Dhaval Patel
4 shared publications
- Supplementary Figure 7 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 5 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Naris Nilubol
4 shared publications
- Supplementary Figure 7 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 5 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Electron Kebebew
4 shared publications
- Supplementary Figure 7 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 5 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Majid Riaz
IQVIA (United Kingdom) (GB)
3 shared publications
- Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative
- Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative
- Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital
M. Daumont
Health Economics and Outcomes Research (United Kingdom) (GB)
3 shared publications
- Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative
- Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative
- Algorithms to identify radiotherapy intent in unresected non-metastatic non-small-cell lung cancer: an I-O Optimise analysis
John R. Penrod
Bristol-Myers Squibb (United States) (US)
3 shared publications
- Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative
- Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative
- Algorithms to identify radiotherapy intent in unresected non-metastatic non-small-cell lung cancer: an I-O Optimise analysis
Emory G. Malone
University of Arkansas for Medical Sciences
3 shared publications
In database
- Role and Regulation of Pif1 Family Helicases at the Replication Fork
- A structural feature of Dda helicase which enhances displacement of streptavidin and <i>trp</i> repressor from <scp>DNA</scp>
- Monitoring helicase-catalyzed unwinding of multiple duplexes simultaneously
Soumen K. Manna
3 shared publications
- Supplementary Figure 5 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Lisa Zhang
3 shared publications
- Supplementary Figure 5 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
- Supplementary Figure 1 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms
Similar Researchers
Based on overlapping research topics
Mathew Newman
Arkansas State University
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications
Alan Herrera-Rueda
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications
Madison P. Lee
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Genomics and Chromatin Dynamics
Muthu V. Kumaran
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Sarah J. Nieman
Hendrix College
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Cancer Cells and Metastasis
Han M
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications